Role of peroxisome proliferator-activated receptor-gamma in alleviating non-alcoholic steatohepatitis (NASH) induced in rats by thymoquinone
• 2014
Publication Information
Authors
AzzaSayedMAwada,EkramNemrAbd Al Haleema, Wesam M El-Baklyb, Mohie A. Sheriefc aDepartment of Pharmacology and Toxicology, Faculty of Pharmacy for Girls, Al-Azhar University, Nasr City, Cairo, Egypt b Department of Pharmacology, Faculty of Medicine, Ain Sh
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background and Aim:Nonalcoholicsteatohepatitis (NASH) is a progressive form of liver disease that leads to advanced fibrosis. Its pathogenesis is not fully known and no specific therapeutic agents are available. Oxidative stress and inflammation play an important role in the progression from simple fatty liver to NASH. Insulin resistance (IR) is commonly associated with it. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) may also play a role in the pathogenesis of NASH. The present study was designed to assess the effects ofthymoquinone (TQ) on liver functions, insulin resistance and PPAR-
Staff Members - Benha University